Sequenom (SQNM -1%) bounces back after saying the USPTO has withdrawn the patent on the...
Sequenom (SQNM -1%) bounces back after saying the USPTO has withdrawn the patent on the company's Diagnosing Fetal Chromosomal Aneuploidy Using Massively Parallel Genomic Sequencing. The agency said it was withdrawn in connection with an anticipated patent interference proceeding between parties with pending patent applications or issued patents directed to similar subject matter.
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs